NSE: LUPIN | BSE: 500257

Mid-range Performer

Download real time

1996.00 27.55 (1.40%)

33.66% Gain from 52W Low

305.6K NSE+BSE Volume

NSE 17 Mar, 2025 2:01 PM (IST)

91,125.6

Market Cap

High in industry

0.6

Beta 1Year

Very Low volatility

US FDA Approval

Lupin gets US FDA tentative approval for Amifampridine tablets, with a market size of $306 million See details

Lupin Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Lupin Ltd. on BSE

Is Lupin Ltd. worth buying?

907 Votes:

Buy 72.66%

Sell 17.64%

Hold 9.7%

RESEARCH REPORTS

Hold SEE REPORTS >

Buy SEE REPORTS >